Security Snapshot

Jazz Pharmaceuticals plc - Common Stock (JAZZ) Institutional Ownership

CUSIP: G50871105

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

567

Shares (Excl. Options)

65,025,031

Price

$189.05

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security identity
Security type / class
Equity / Common Stock
Symbol
JAZZ on Nasdaq
Issuer context
Shares outstanding
61,577,817
Reported price per share
$226.96
Latest holder snapshot
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
65,025,031
Total reported value
$12,279,899,848
Portfolio coverage rank
0.01%
Share change
+3,496,881
Value change
+$701,645,439
Number of holders
567
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • JAZZ - Jazz Pharmaceuticals plc - Common Stock is tracked under CUSIP G50871105.
  • 567 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 573 to 567 between Q4 2025 and Q1 2026.
  • Reported value moved from $10,480,482,425 to $12,279,899,848.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 567 institutions filings for Q1 2026.

Open SEC Evidence

Security key

G50871105

Latest holder period

Q1 2026

13F holders

567

13D/G owners

1

CIK / CUSIP context first

Open Q1 2026 holders JAZZ full holder history Jazz Pharmaceuticals plc SEC filings Jazz Pharmaceuticals plc company facts Jazz Pharmaceuticals plc insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
JAZZ
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 5% $633,056,418 3,103,522 Vanguard Capital Management 31 Mar 2026

As of 31 Mar 2026, 567 institutional investors reported holding 65,025,031 shares of Jazz Pharmaceuticals plc - Common Stock (JAZZ). This represents 106% of the company’s total 61,577,817 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
70%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.1% 5,591,700 +2.6% 0.02% $1,057,110,973
VANGUARD PORTFOLIO MANAGEMENT LLC 4.8% 2,983,242 0% 0.03% $563,981,900
Capital World Investors 4.3% 2,673,376 +0.25% 0.07% $505,401,733
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 2,648,333 0% 0.01% $500,667,354
LSV ASSET MANAGEMENT 3.9% 2,386,840 -2.8% 0.97% $451,232,000
FMR LLC 3.7% 2,275,762 +184% 0.02% $430,232,708
FRANKLIN RESOURCES INC 3.2% 1,958,940 +7.7% 0.09% $370,337,696
DIMENSIONAL FUND ADVISORS LP 3.1% 1,895,215 -28% 0.07% $358,264,016
STATE STREET CORP 3.1% 1,891,646 +2.9% 0.01% $357,615,676
EcoR1 Capital, LLC 2.8% 1,706,469 0% 14% $322,607,964
Bank of New York Mellon Corp 2.7% 1,679,371 +45% 0.06% $317,485,045
FULLER & THALER ASSET MANAGEMENT, INC. 2.7% 1,676,142 -0.06% 1.1% $316,874,674
AMERIPRISE FINANCIAL INC 2.6% 1,608,476 +5.7% 0.07% $304,082,388
AQR CAPITAL MANAGEMENT LLC 2.2% 1,338,458 +53% 0.11% $249,863,354
MILLENNIUM MANAGEMENT LLC 2.1% 1,262,511 +5% 0.18% $238,677,705
CITADEL ADVISORS LLC 2% 1,259,444 +305% 0.17% $238,097,888
GEODE CAPITAL MANAGEMENT, LLC 2% 1,237,617 +3.4% 0.01% $234,026,208
JPMORGAN CHASE & CO 2% 1,204,353 +15% 0.01% $220,577,545
BANK OF AMERICA CORP /DE/ 1.6% 1,014,800 +11% 0.01% $191,847,960
Swedbank AB 1.6% 992,108 -10% 0.2% $187,558,018
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 1.4% 885,201 +25% 0.19% $167,347,248
RENAISSANCE TECHNOLOGIES LLC 1.3% 819,374 -2.1% 0.24% $154,902,655
Holocene Advisors, LP 1.2% 733,905 +24% 0.34% $138,744,740
MORGAN STANLEY 1.1% 698,738 +9.3% 0.01% $132,096,707
Allianz Asset Management GmbH 0.99% 610,297 +1.9% 0.13% $115,376,648

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 65,025,031 $12,279,899,848 +$701,645,439 $189.05 567
2025 Q4 61,702,488 $10,480,482,425 +$192,241,807 $170.00 573
2025 Q3 60,646,127 $7,990,617,646 -$150,715,669 $131.80 498
2025 Q2 61,824,515 $6,561,677,298 +$172,218,482 $106.12 497
2025 Q1 59,973,813 $7,442,798,617 +$115,230,167 $124.15 545
2024 Q4 59,002,163 $7,265,494,814 +$147,830,867 $123.15 502
2024 Q3 57,597,455 $6,415,433,594 +$58,344,093 $111.41 469
2024 Q2 57,463,700 $6,133,341,626 -$38,433,148 $106.73 451
2024 Q1 57,711,183 $6,947,614,300 +$89,820,559 $120.42 475
2023 Q4 57,060,984 $7,017,863,210 -$56,981,989 $123.00 491
2023 Q3 56,530,271 $7,318,098,320 -$17,277,114 $129.44 482
2023 Q2 56,728,151 $7,039,068,770 -$22,114,573 $123.97 465
2023 Q1 56,681,319 $8,292,329,555 +$108,158,178 $146.33 462
2022 Q4 56,178,304 $8,948,272,058 -$100,056,709 $159.31 475
2022 Q3 56,928,016 $7,590,657,250 -$96,379,512 $133.29 443
2022 Q2 57,260,089 $8,932,716,610 +$138,065,500 $156.01 448
2022 Q1 56,748,008 $8,837,789,303 -$111,358,494 $155.67 437
2021 Q4 57,664,502 $7,350,056,970 +$21,422,030 $127.40 422
2021 Q3 56,879,540 $7,407,482,783 -$119,725,201 $130.21 422
2021 Q2 57,178,368 $10,156,395,395 +$780,868,772 $177.64 481
2021 Q1 53,127,709 $8,729,942,643 +$29,540,811 $164.37 435
2020 Q4 52,654,654 $8,685,222,791 -$294,935,573 $165.05 428
2020 Q3 54,543,371 $7,767,396,418 +$369,110,226 $142.59 382
2020 Q2 52,094,206 $5,741,576,836 +$270,141,092 $110.34 376
2020 Q1 49,800,360 $4,968,187,513 -$262,951,825 $99.74 397
2019 Q4 51,855,668 $7,738,313,733 +$162,667,912 $149.28 436
2019 Q3 50,956,459 $6,527,263,115 +$97,208,216 $128.14 397
2019 Q2 50,088,303 $7,125,707,525 +$206,804,403 $142.56 407
2019 Q1 51,378,205 $7,336,806,884 -$212,277,925 $142.95 415
2018 Q4 52,922,692 $6,549,889,371 -$427,140,677 $123.96 409
2018 Q3 55,400,378 $9,303,697,145 -$146,566,478 $168.13 397
2018 Q2 56,183,461 $9,670,926,964 +$435,954,554 $172.30 373
2018 Q1 53,679,721 $8,093,065,376 -$76,065,361 $150.99 320
2017 Q4 54,247,348 $7,295,659,971 -$66,672,908 $134.65 319
2017 Q3 54,642,574 $7,995,262,702 +$210,111,108 $146.25 299
2017 Q2 53,141,372 $8,263,546,157 +$374,758,650 $155.50 314
2017 Q1 52,283,523 $7,587,950,162 +$512,523,733 $145.13 302
2016 Q4 52,085,929 $5,676,848,580 -$158,899,374 $109.03 287
2016 Q3 53,391,287 $6,483,323,799 -$52,478,840 $121.48 317
2016 Q2 53,886,553 $7,614,644,976 -$43,527,577 $141.31 354
2016 Q1 54,554,481 $7,120,724,289 -$230,482,851 $130.55 330
2015 Q4 56,253,036 $7,906,867,974 -$16,787,687 $140.56 338
2015 Q3 56,363,725 $7,485,153,388 +$25,070,936 $132.81 350
2015 Q2 55,981,344 $9,856,454,549 +$619,952,018 $176.07 367
2015 Q1 52,457,739 $9,064,673,642 -$333,658,314 $172.79 352
2014 Q4 54,301,590 $8,892,764,640 +$176,201,808 $163.73 351
2014 Q3 53,225,671 $8,544,993,638 +$384,771,818 $160.56 320
2014 Q2 50,728,244 $7,457,848,518 +$45,563,248 $147.01 299
2014 Q1 50,472,408 $6,997,331,929 +$318,974,123 $138.68 310
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .